Author information:
(1)Department of Biomedical, Experimental and Clinical Sciences 'Mario Serio', 
University of Florence, Viale Morgagni, 50 50134 Florence, Italy; Department of 
Neuroscience, Psychology, Area of Medicine and Health of the Child of the 
University of Florence, Viale Pieraccini, 6, 50139 Florence, Italy.
(2)Department of Physics, University of Genova, via Dodecaneso 33, 16146, 
Genova, Italy.
(3)Department of Molecular Medicine, Institute of Biochemistry, University of 
Pavia, Viale Taramelli 3/B, 27100 Pavia, Italy.
(4)Department of Molecular Medicine, Institute of Biochemistry, University of 
Pavia, Viale Taramelli 3/B, 27100 Pavia, Italy; Wolfson Drug Discovery Unit, 
Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine Royal Free 
Campus, University College London, NW3 2PF London, UK.
(5)Department of Biomedical, Experimental and Clinical Sciences 'Mario Serio', 
University of Florence, Viale Morgagni, 50 50134 Florence, Italy.
(6)Department of Molecular Medicine, Institute of Biochemistry, University of 
Pavia, Viale Taramelli 3/B, 27100 Pavia, Italy; Wolfson Drug Discovery Unit, 
Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine Royal Free 
Campus, University College London, NW3 2PF London, UK; Interuniversity Center 
for the Study of Neurodegenerative Diseases (CIMN), Florence, Italy.
(7)Department of Biomedical, Experimental and Clinical Sciences 'Mario Serio', 
University of Florence, Viale Morgagni, 50 50134 Florence, Italy; 
Interuniversity Center for the Study of Neurodegenerative Diseases (CIMN), 
Florence, Italy.
(8)Department of Biomedical, Experimental and Clinical Sciences 'Mario Serio', 
University of Florence, Viale Morgagni, 50 50134 Florence, Italy; 
Interuniversity Center for the Study of Neurodegenerative Diseases (CIMN), 
Florence, Italy. Electronic address: monica.bucciantini@unifi.it.